𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During Pregnancy

✍ Scribed by Einarson, Adrienne; Pistelli, Alessandra; DeSantis, Marco; Malm, Heli; Paulus, Wolfgang D.; Panchaud,, Alice; Kennedy, Debra; Einarson, Thomas R.; Koren, Gideon


Book ID
119986103
Publisher
American Psychiatric Publishing Inc
Year
2008
Tongue
English
Weight
101 KB
Volume
165
Category
Article
ISSN
0002-953X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Beta2-agonists use during pregnancy and
✍ Sherif Eltonsy; AmΓ©lie Forget; Lucie Blais πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Treatment of asthma symptoms during pregnancy is crucial for maternal and fetal health. Short‐acting beta~2~‐agonists (SABA) are frequently used as rescue medications and long‐acting beta~2~‐agonists (LABA) are used as add‐on controller therapy for asthma during pregnancy